APP and Alzheimer disease: Disease progression is characterized pathologically by the progressive appearance of proinflammatory, highly insoluble, amyloid-beta peptide (Aβ)-enriched pathological lesions known as neocortical senile plaques in the brain parenchyma and retinal drusen in the macular region in AD and AMD, respectively.